Further processing options
Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer
Saved in:
Journal Title: | Clinical Cancer Research |
---|---|
Authors and Corporations: | , , , , , , , , , , , , , , , |
In: | Clinical Cancer Research, 25, 2019, 1, p. 277-289 |
Type of Resource: | E-Article |
Language: | English |
published: |
American Association for Cancer Research (AACR)
|
Subjects: |